Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

KPV

Lys-Pro-Val, α-MSH (11-13)

Quick Stats
Studies 104
Trials 57
Score 2
2006 pubmed

Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing: role of nitric oxide.

Bonfiglio. Vincenza V; Camillieri. Giovanni G; Avitabile. Teresio T; Leggio. Gian Marco GM; Drago. Filippo F

Key Findings

  • Topical KPV (1‑10 mg/ml) accelerates corneal epithelial wound closure in rabbits
  • KPV’s effect is similar to a nitric‑oxide donor (sodium nitroprusside)
  • Inhibiting nitric‑oxide synthase with L‑NAME abolishes KPV’s healing benefit

Practical Outcomes

  • For eye‑focused biohackers, KPV suggests a potential fast‑acting eye‑drop to aid corneal repair, but it’s only proven in rabbits, lacks human safety data, and would need proper formulation and dosing studies before practical use.

Summary

A short piece of the hormone alpha‑MSH called KPV, when applied as eye drops, helped rabbit corneas heal faster, and this benefit seemed to rely on nitric‑oxide; the effect disappeared when nitric‑oxide production was blocked.

Abstract

It is known that alpha-melanocyte stimulating hormone (alpha-MSH) may exert anti-inflammatory effects and facilitate reparative processes in different tissues. The effective message sequence of alpha-MSH resides in the COOH-terminal tripeptide alpha-MSH(11-13). This study was undertaken to investigate the effects of topical administration of the COOH-terminal tripeptide sequence of alpha-MSH (alpha-MSH(11-13), KPV) on corneal epithelial wound healing in rabbits and the possible role of nitric oxide (NO) in these effects. The whole corneal epithelium was denuded in both eyes by mechanical abrasion. The area of the corneal epithelial defect was stained with fluorescein, photographed, and then measured before the treatment and every 12 h by a computerized software. The mean epithelial wound area and the mean percent of epithelial defect remaining at each follow-up control were compared between experimental groups. Rabbits were topically treated with KPV 1, 5 or 10 mg/ml (30 microl), two drops four times in a day, for 4 days, starting immediately after corneal abrasion, while control animals received topical phosphate-buffered saline as vehicle. In order to study the role of NO in corneal repair processes, the NO donor, sodium nitroprusside (SP, 10 mg/ml, 30 microl) was administered in both eyes, two drops four times in a day, for 4 days. The effects of KPV or SP were challenged by pre-treatment with the nitric oxide synthase inhibitor, N omega-nitro-L-arginine methyl ester (L-NAME, 10 mg/ml, 30 microl) 30 min prior to KPV or SP instillation. The mean percent epithelial defect remaining each time was significantly smaller in animals treated with KPV or SP in comparison to controls. Sixty hours later, eight out of eight (100%) corneas treated with KPV or SP were completely re-epithelized (P<0.05) while none of the corneas treated with placebo were re-epithelized. Pre-treatment with L-NAME inhibited the facilitating effect of KPV on corneal epithelial wound healing process and totally prevented the effect of SP. Rabbit corneal epithelial cells (RCE) in culture were exposed for 1, 6 and 24 h to different KPV concentrations (0.1, 1 and 10 microM) in medium containing 15% foetal bovine serum (FBS). Cell viability was stimulated by 1 and 10 microM concentrations of the substance. Thus, KPV may facilitate corneal epithelial wound healing in rabbits with a mechanism that may involve NO disposition in corneal tissue. However, it is not known whether this mechanism is likely to depend on a direct stimulating repairing activity shared by the entire molecule of alpha-MSH.

Study Information

Provider

pubmed

Year

2006

Date

2006-09-11T00:00:00.000Z

DOI

10.1016/j.exer.2006.07.014